Half-year report · Q2

Period2024-04-01 → 2024-09-30
Filed2024-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥1.1bn2024-04-01 → 2024-09-30Cons.Net sales
Revenue¥2.3bn2023-04-01 → 2024-03-31Cons.Net sales (5-year summary)
Revenue¥1.1bn2023-04-01 → 2023-09-30Cons.Net sales
Operating income−¥84m2024-04-01 → 2024-09-30Cons.Operating income
Operating income−¥116m2023-04-01 → 2023-09-30Cons.Operating income
Ordinary income−¥78m2024-04-01 → 2024-09-30Cons.Ordinary income
Ordinary income−¥168m2023-04-01 → 2024-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income−¥114m2023-04-01 → 2023-09-30Cons.Ordinary income
Profit before tax−¥79m2024-04-01 → 2024-09-30Cons.Income before income taxes
Profit before tax−¥101m2023-04-01 → 2023-09-30Cons.Income before income taxes
Net income (owners)−¥82m2024-04-01 → 2024-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)−¥176m2023-04-01 → 2024-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)−¥104m2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income−¥82m2024-04-01 → 2024-09-30Cons.Profit loss
Net income−¥104m2023-04-01 → 2023-09-30Cons.Profit loss
Total assets¥2.1bnat 2024-09-30Cons.Assets
Total assets¥1.7bnat 2024-03-31Cons.Assets
Total assets¥1.5bnat 2023-09-30Cons.Total assets (5-year summary)
Total liabilities¥694mat 2024-09-30Cons.Liabilities
Total liabilities¥477mat 2024-03-31Cons.Liabilities
Net assets / equity¥1.4bnat 2024-09-30Cons.Net assets
Net assets / equity¥1.2bnat 2024-03-31Cons.Net assets
Net assets / equity¥1.1bnat 2023-09-30Cons.Net assets (5-year summary)
Cash and deposits¥190mat 2024-09-30Cons.Cash and deposits
Cash and deposits¥297mat 2024-03-31Cons.Cash and deposits
Cash & equivalents¥190mat 2024-09-30Cons.Cash and cash equivalents
Cash & equivalents¥297mat 2024-03-31Cons.Cash and cash equivalents
Cash & equivalents¥238mat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥173mat 2023-03-31dCons.Cash and cash equivalents
Operating cash flow−¥248m2024-04-01 → 2024-09-30Cons.Net cash provided by used in operating activities
Operating cash flow−¥77m2023-04-01 → 2024-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow−¥54m2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥432m2024-04-01 → 2024-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥87m2023-04-01 → 2024-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥6m2023-04-01 → 2023-09-30Cons.Net cash provided by used in investment activities
Financing cash flow¥573m2024-04-01 → 2024-09-30Cons.Net cash provided by used in financing activities
Financing cash flow¥288m2023-04-01 → 2024-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥126m2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥-1.382024-04-01 → 2024-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-3.312023-04-01 → 2024-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-22023-04-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio65.9%at 2024-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio71.2%at 2024-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio72.7%at 2023-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 32
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment profit2024-04-01 → 2024-09-30−¥59m
jpcrp040300-q2r_E05674-000Beauty And Wellness Businessreportable segmentrevenue2024-04-01 → 2024-09-30¥500m
jpcrp040300-q2r_E05674-000Beauty And Wellness Businessreportable segmentrevenue external2024-04-01 → 2024-09-30¥500m
jpcrp040300-q2r_E05674-000Beauty And Wellness Businessreportable segmentsegment profit2024-04-01 → 2024-09-30¥10m
jpcrp040300-q2r_E05674-000Cosmetics Businessreportable segmentrevenue2024-04-01 → 2024-09-30¥439m
jpcrp040300-q2r_E05674-000Cosmetics Businessreportable segmentrevenue external2024-04-01 → 2024-09-30¥439m
jpcrp040300-q2r_E05674-000Cosmetics Businessreportable segmentsegment profit2024-04-01 → 2024-09-30¥2m
jpcrp040300-q2r_E05674-000Regenerative Medicine Related Businessreportable segmentrevenue2024-04-01 → 2024-09-30¥181m
jpcrp040300-q2r_E05674-000Regenerative Medicine Related Businessreportable segmentrevenue external2024-04-01 → 2024-09-30¥181m
jpcrp040300-q2r_E05674-000Regenerative Medicine Related Businessreportable segmentsegment profit2024-04-01 → 2024-09-30−¥9m
jpcrp040300-q2r_E05674-000Sustainable Businessreportable segmentrevenue2024-04-01 → 2024-09-30¥3m
jpcrp040300-q2r_E05674-000Sustainable Businessreportable segmentrevenue external2024-04-01 → 2024-09-30¥3m
jpcrp040300-q2r_E05674-000Sustainable Businessreportable segmentsegment profit2024-04-01 → 2024-09-30−¥29m
—segment totalrevenue2024-04-01 → 2024-09-30¥1.1bn
—segment totalrevenue external2024-04-01 → 2024-09-30¥1.1bn
—segment totalsegment profit2024-04-01 → 2024-09-30−¥26m
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-09-30−¥40m
jpcrp040300-q2r_E05674-000Beauty And Wellness Businessreportable segmentrevenue2023-04-01 → 2023-09-30¥538m
jpcrp040300-q2r_E05674-000Beauty And Wellness Businessreportable segmentrevenue external2023-04-01 → 2023-09-30¥538m
jpcrp040300-q2r_E05674-000Beauty And Wellness Businessreportable segmentsegment profit2023-04-01 → 2023-09-30¥16m
jpcrp040300-q2r_E05674-000Cosmetics Businessreportable segmentrevenue2023-04-01 → 2023-09-30¥395m
jpcrp040300-q2r_E05674-000Cosmetics Businessreportable segmentrevenue external2023-04-01 → 2023-09-30¥395m
jpcrp040300-q2r_E05674-000Cosmetics Businessreportable segmentsegment profit2023-04-01 → 2023-09-30−¥56m
jpcrp040300-q2r_E05674-000Regenerative Medicine Related Businessreportable segmentrevenue2023-04-01 → 2023-09-30¥168m
jpcrp040300-q2r_E05674-000Regenerative Medicine Related Businessreportable segmentrevenue external2023-04-01 → 2023-09-30¥168m
jpcrp040300-q2r_E05674-000Regenerative Medicine Related Businessreportable segmentsegment profit2023-04-01 → 2023-09-30¥1m
jpcrp040300-q2r_E05674-000Sustainable Businessreportable segmentrevenue2023-04-01 → 2023-09-30¥3m
jpcrp040300-q2r_E05674-000Sustainable Businessreportable segmentrevenue external2023-04-01 → 2023-09-30¥3m
jpcrp040300-q2r_E05674-000Sustainable Businessreportable segmentsegment profit2023-04-01 → 2023-09-30−¥37m
—segment totalrevenue2023-04-01 → 2023-09-30¥1.1bn
—segment totalrevenue external2023-04-01 → 2023-09-30¥1.1bn
—segment totalsegment profit2023-04-01 → 2023-09-30−¥76m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 489
ItemContextValueUnit
Number of shares heldCurrentQuarterInstant_No2MajorShareholdersMember4308000
Shareholding ratioCurrentQuarterInstant_No2MajorShareholdersMember0.071
Number of shares heldCurrentQuarterInstant_No3MajorShareholdersMember2000000
Shareholding ratioCurrentQuarterInstant_No3MajorShareholdersMember0.033
Number of shares heldCurrentQuarterInstant_No4MajorShareholdersMember1739900
Shareholding ratioCurrentQuarterInstant_No4MajorShareholdersMember0.029
Number of shares heldCurrentQuarterInstant_No5MajorShareholdersMember1474916
Shareholding ratioCurrentQuarterInstant_No5MajorShareholdersMember0.024
Number of shares heldCurrentQuarterInstant_No6MajorShareholdersMember1412900
Shareholding ratioCurrentQuarterInstant_No6MajorShareholdersMember0.023
Number of shares heldCurrentQuarterInstant_No7MajorShareholdersMember1181400
Shareholding ratioCurrentQuarterInstant_No7MajorShareholdersMember0.020
Number of shares heldCurrentQuarterInstant_No8MajorShareholdersMember676100
Shareholding ratioCurrentQuarterInstant_No8MajorShareholdersMember0.011
Number of shares heldCurrentQuarterInstant_No9MajorShareholdersMember655000
Shareholding ratioCurrentQuarterInstant_No9MajorShareholdersMember0.011
Number of shares heldCurrentQuarterInstant_No10MajorShareholdersMember505500
Shareholding ratioCurrentQuarterInstant_No10MajorShareholdersMember0.008
Number of shares heldCurrentQuarterInstant34608816
Shareholding ratioCurrentQuarterInstant0.574
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithNoVotingRightsMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember-
Number of voting rights issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithFullVotingRightsTreasurySharesEtcMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember60306600
Number of voting rights issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember603066
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember2916
Number of shares issued shares voting rightsCurrentQuarterInstant60309516
Number of voting rights issued shares voting rightsCurrentQuarterInstant603066
Cash and depositsPrior1YearInstant296585000JPY
Cash and depositsCurrentQuarterInstant189792000JPY
Notes and accounts receivable tradePrior1YearInstant243290000JPY
Notes and accounts receivable tradeCurrentQuarterInstant176278000JPY
Merchandise and finished goodsPrior1YearInstant726359000JPY
Merchandise and finished goodsCurrentQuarterInstant719470000JPY
Raw materials and suppliesPrior1YearInstant60868000JPY
Raw materials and suppliesCurrentQuarterInstant43577000JPY
Accounts receivable otherPrior1YearInstant1932000JPY
Accounts receivable otherCurrentQuarterInstant1452000JPY
Other caPrior1YearInstant37504000JPY
Other caCurrentQuarterInstant200895000JPY
Allowance for doubtful accounts caPrior1YearInstant-370000JPY
Allowance for doubtful accounts caCurrentQuarterInstant-390000JPY
Current assetsPrior1YearInstant1366170000JPY
Current assetsCurrentQuarterInstant1331075000JPY
Buildings and structuresPrior1YearInstant33407000JPY
Buildings and structuresCurrentQuarterInstant35622000JPY
Accumulated depreciation buildings and structuresPrior1YearInstant-22588000JPY
Accumulated depreciation buildings and structuresCurrentQuarterInstant-23220000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2024-03-31pass rounding
balance sheet identityconsolidated 2024-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2024-03-31pass
statement vs summary · net assetsconsolidated 2024-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2024-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2024-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2024-04-01/2024-09-30pass
statement vs summary · total assetsconsolidated 2024-03-31pass
statement vs summary · total assetsconsolidated 2024-09-30pass